Most peptide evidence measures hormone levels rather than strength or lean-mass gains
HERE is the Business Insider article referenced in this episode
Reference: Haddad PM et al
We then measure and optimize performance in real-time to maximize your brands ROI
In a recent, large clinical trial involving more than 17,000 adults living with overweight or obesity and established heart disease, participants who received a weekly semaglutide injection experienced a 20% reduction in major adverse cardiovascular events (MACE), such as heart attack and stroke, compared to those who didnt take the medication
By Lana Pine | Published on September 16, 2025 4 min read Overall, GLP-1 receptor agonists (GLP-1 RAs) appear to be effective and relatively safe for kids and teens, at least in the short term, in helping with blood sugar control, weight and heart-related health risks, according to a new study published in JAMA Pediatrics